Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects [Phase 1]
A Phase 1 study in healthy subjects evaluated the potential pharmacokinetic interaction and renal effects when bumetanide (1 mg) is co-admin…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic drug interaction study assessing potential interactions between dapagliflozin and glimepiride or sitagliptin in heal…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes [Phase 1]
A Phase 1 trial comparing subcutaneous insulin glargine with subcutaneous insulin aspart in adults with Type 2 diabetes; the study has compl…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects [Phase 1]
A Phase 1 study evaluated whether dapagliflozin affects the pharmacokinetics of warfarin and digoxin in healthy subjects. The study is compl…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Renal Impairment in Type 2 Diabetic Subjects [Phase 1]
This Phase 1 trial update from AstraZeneca investigates renal impairment in subjects with Type 2 diabetes mellitus.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin [Phase 2]
A Phase 2 study comparing the pharmacodynamic effects of lixisenatide versus liraglutide in patients with type 2 diabetes inadequately contr…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients [Phase 3]
Phase 3 trial evaluating lixisenatide versus placebo as add-on therapy to basal insulin and/or oral antidiabetic treatment in older adults w…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) [Phase 3]
A Phase 3 clinical trial evaluated cardiovascular outcomes in patients with type 2 diabetes after an acute coronary syndrome while treated w…
-
EMA label_change · 2016-10-14Use of metformin to treat diabetes now expanded to patients with moderately reduced kidney function
The European Medicines Agency expands the use of metformin to treat diabetes in patients with moderately reduced kidney function.
-
CLINICAL_TRIALS research · 2016-10-14Clinical Trial Update: A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Bangladesh
This completed clinical trial survey funded by Novo Nordisk evaluated diabetes management, control, chronic complications, and psychosocial …
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin [Phase 3]
Phase 3 trial comparing lixisenatide given before the main meal versus before breakfast in adults with type 2 diabetes on metformin; results…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of Mesenchymal precursor cells for diabetic nephropathy has completed. The spo…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care [NA]
A completed clinical trial evaluating an educational intervention aimed at improving diabetes care by addressing patients' literacy and nume…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: NovoLet® Acceptance Study Within the Hospital Practise in Indonesia
Update on a NovoLet acceptance trial conducted in Indonesian hospital practice; the study involving diabetes patients (Type 1 and Type 2) ha…
-
CLINICAL_TRIALS research · 2016-10-14Clinical Trial Update: Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients [Phase 4]
Phase 4 clinical trial comparing aSpirin with cilostazol for inhibition of antiplatelet aggregation in patients with Type 2 diabetes mellitu…
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin [Phase 3]
Phase 3 trial update on the efficacy and safety of lixisenatide added to metformin in patients with Type 2 Diabetes Mellitus inadequately co…
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: A Decade of Sleeve Gastrectomy: Analysis of Short and Long-term Outcome of 562 Patients
A decade-long analysis of sleeve gastrectomy outcomes in 562 patients, reporting short- and long-term results and effects on obesity-related…
-
CLINICAL_TRIALS research · 2016-10-13Clinical Trial Update: Autonomic Cardiovascular Neuropathy in Recently Diagnosed DM2 Patients (ACNDM2)
This clinical trial update covers a study on autonomic cardiovascular neuropathy in recently diagnosed Type 2 diabetes mellitus patients, fo…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin [Phase 3]
Phase 3 clinical trial results evaluate lixisenatide added to basal insulin for glycemic control and safety in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes [Phase 2]
Phase 2 study comparing lixisenatide with liraglutide on postprandial plasma glucose in patients with Type 2 Diabetes Mellitus; results were…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine [Phase 3]
Phase 3 trial evaluating 24 weeks of lixisenatide added to metformin and insulin glargine in type 2 diabetes patients with inadequate glycem…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA) [Phase 3]
Phase 3 trial update evaluating lixisenatide added to basal insulin (with or without sulfonylurea) in type 2 diabetes for glycemic control a…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone [Phase 3]
A Phase 3 trial evaluated adding lixisenatide to pioglitazone in adults with type 2 diabetes to improve glycemic control and assess safety. …
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus [NA]
This document reports on a completed clinical trial evaluating the glycemic response to three oral nutrition supplements in adults with Type…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years [Phase 3]
Phase 3 trial comparing lixisenatide to sitagliptin as add-on therapy to metformin in obese adults with type 2 diabetes; the study is comple…